MicroRNA 9-3p Targets β(1) Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition

le Zawistowski, Jon S., Nakamura, Kazuhiro, Parker, Joel S., Granger, Deborah A., Golitz, Brian T., Johnson, Gary L.
Foilsithe 2013

SWI/SNF Chromatin-Remodeling Factor Smarcd3/Baf60c Controls Epithelial-Mesenchymal Transition by Inducing Wnt5a Signaling

le Jordan, Nicole Vincent, Prat, Aleix, Abell, Amy N., Zawistowski, Jon S., Sciaky, Noah, Karginova, Olga A., Zhou, Bingying, Golitz, Brian T., Perou, Charles M., Johnson, Gary L.
Foilsithe 2013

PARC/CUL9 Mediates the Degradation of Mitochondrial-released Cytochrome c and Promotes Survival in Neurons and Cancer Cells

le Gama, Vivian, Swahari, Vijay, Schafer, Johanna, Kole, Adam J., Evans, Allyson, Huang, Yolanda, Cliffe, Anna, Golitz, Brian, Sciaky, Noah, Pei, Xin-Hai, Xiong, Yue, Deshmukh, Mohanish
Foilsithe 2014

GSK2801, a BAZ2/BRD9 bromodomain inhibitor, synergizes with BET inhibitors to induce apoptosis in triple-negative breast cancer.

le Bevill, Samantha M., Olivares-Quintero, Jose F., Sciaky, Noah, Golitz, Brian T., Singh, Darshan, Beltran, Adriana S., Rashid, Naim U., Stuhlmiller, Timothy J., Hale, Andrew, Moorman, Nathaniel J., Santos, Charlene M., Angus, Steven P., Zawistowski, Jon S., Johnson, Gary L.
Foilsithe in Mol Cancer Res (2019)

TMIC-25. DISSECTING THE ROLE OF HOST GENETICS IN GLIOMA EVOLUTION USING GENETICALLY-ENGINEERED MOUSE MODELS AND THE COLLABORATIVE CROSS

le Skinner, Kasey, Ferris, Martin, Bash, Ryan, Shelton, Abigail, Smithberger, Erin, Angus, Steven, Golitz, Brian, Sciacky, Noah, Simon, Jeremy, Stein, Jason, Matsushima, Glenn, Ostrom, Quinn, Stetson, Lindsay, Barnholtz-Sloan, Jill, Dhruv, Harshil, Berens, Michael, de Villena, Fernando Pardo Manuel, Miller, Ryan
Foilsithe in Neuro Oncol (2018)

Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy

le Lipner, Matthew B., Peng, Xianlu L., Jin, Chong, Xu, Yi, Gao, Yanzhe, East, Michael P., Rashid, Naim U., Moffitt, Richard A., Herrera Loeza, Silvia G., Morrison, Ashley B., Golitz, Brian T., Vaziri, Cyrus, Graves, Lee M., Johnson, Gary L., Yeh, Jen Jen
Foilsithe in JCI Insight (2020)

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

le Van Swearingen, Amanda E D, Sambade, Maria J, Siegel, Marni B, Sud, Shivani, McNeill, Robert S, Bevill, Samantha M, Chen, Xin, Bash, Ryan E, Mounsey, Louisa, Golitz, Brian T, Santos, Charlene, Deal, Allison, Parker, Joel S, Rashid, Naim, Miller, C Ryan, Johnson, Gary L, Anders, Carey K
Foilsithe in Neuro Oncol (2017)

Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth

le Krulikas, Linas J., McDonald, Ian M., Lee, Benjamin, Okumu, Denis O., East, Michael P., Gilbert, Thomas S. K., Herring, Laura E., Golitz, Brian T., Wells, Carrow I., Axtman, Allison D., Zuercher, William J., Willson, Timothy M., Kireev, Dmitri, Yeh, Jen Jen, Johnson, Gary L., Baines, Antonio T., Graves, Lee M.
Foilsithe in SLAS Discov (2018)

Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacological Targeting of the P-TEFb Complex

le Zawistowski, Jon S., Bevill, Samantha M., Goulet, Daniel R., Stuhlmiller, Timothy J., Beltran, Adriana S., Olivares-Quintero, Jose F., Singh, Darshan, Sciaky, Noah, Parker, Joel S., Rashid, Naim U., Chen, Xin, Duncan, James S., Whittle, Martin C., Angus, Steven P., Velarde, Sara Hanna, Golitz, Brian T., He, Xiaping, Santos, Charlene, Darr, David B., Gallagher, Kristalyn, Graves, Lee M., Perou, Charles M., Carey, Lisa A., Earp, H. Shelton, Johnson, Gary L.
Foilsithe in Cancer Discov (2017)